Cetuximab in Combination With Chemotherapy for the Treatment of Metastatic Colorectal Cancer
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01564810|
Recruitment Status : Unknown
Verified October 2012 by Xu jianmin, Fudan University.
Recruitment status was: Recruiting
First Posted : March 28, 2012
Last Update Posted : October 24, 2012
Information provided by (Responsible Party):
Xu jianmin, Fudan University
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Unknown|
|Actual Primary Completion Date :||June 2012|
|Estimated Study Completion Date :||September 2015|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Ye LC, Liu TS, Ren L, Wei Y, Zhu DX, Zai SY, Ye QH, Yu Y, Xu B, Qin XY, Xu J. Randomized controlled trial of cetuximab plus chemotherapy for patients with KRAS wild-type unresectable colorectal liver-limited metastases. J Clin Oncol. 2013 Jun 1;31(16):1931-8. doi: 10.1200/JCO.2012.44.8308. Epub 2013 Apr 8.